Published in Genomics and Genetics Weekly, June 16th, 2006
Study 1: Preproghrelin Leu72Met polymorphism is not associated with type 2 diabetes mellitus.
"Ghrelin is a novel gut-brain peptide, which exerts somatotropic, orexigenic, and adipogenic effects. Genetic variants of ghrelin have been associated with both obesity and insulin metabolism," investigators in South Korea report.
"In this study," proposed S.Y. Kim and colleagues, Chonbuk National University Medical School, "we determined a role of preproghrelin Leu72Met polymorphism on type 2 diabetes mellitus and its relationship to variables studied....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genomics and Genetics Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.